Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 262

Results For "PLI"

2768 News Found

India-Sweden Healthcare innovation challenge launched
Drug Approval | August 17, 2021

India-Sweden Healthcare innovation challenge launched

The focus of this year’s challenge is to find solutions within Covid management and treatment of cardiovascular, renal, neuro, cancer and lung diseases


Manjushree Technopack set to acquire Classy Kontainers
Packaging | August 17, 2021

Manjushree Technopack set to acquire Classy Kontainers

MTL, with over 40 years of experience in packaging, caters to the requirements of the FMCG, F&B, homecare, personal care, agrochemicals, pharmaceutical, and liquor industries


India restricts export of Rapid Antigen Test Kits used to detect Covid 19
Policy | August 16, 2021

India restricts export of Rapid Antigen Test Kits used to detect Covid 19

The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT


Apollo Hospitals inks MoU with Group of Hospitals for liver transplant
Healthcare | August 14, 2021

Apollo Hospitals inks MoU with Group of Hospitals for liver transplant

The MoU was signed on World Organ Donation Day which falls on August 13


Bharat Biotech’s first nasal vaccine gets approval for Phase 2 trials
Biotech | August 14, 2021

Bharat Biotech’s first nasal vaccine gets approval for Phase 2 trials

This is the first of its kind vaccine for Covid 19 to get the go-ahead


Syngene sets up microbial facility as it expands biopharma-manufacturing capacity
Biotech | August 13, 2021

Syngene sets up microbial facility as it expands biopharma-manufacturing capacity

It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies


USFDA grants distinct indication for Chronic Sleep Disorder
Drug Approval | August 13, 2021

USFDA grants distinct indication for Chronic Sleep Disorder

Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder


HCG Q1 revenue at Rs 326.58 cr. 67 per cent increase YoY
Healthcare | August 13, 2021

HCG Q1 revenue at Rs 326.58 cr. 67 per cent increase YoY

Substantial reduction in losses


Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%
Drug Approval | August 12, 2021

Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%

It’s an AB-rated generic therapeutic version of Durezol


Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness
Drug Approval | August 12, 2021

Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness

A treatment to prevent extreme symptoms and cut hospitalisation